DeutschNewstral
Article
bizjournals.com on 2016-05-26 21:39
Reata Pharmaceuticals surges more than 23 percent in stock debut
Related news
- BReata Stock Surges. Biogen Is Buying It for $7.3 Billion in Cash.1 min readbarrons.com
Roku surges 30% in stock market debutTechCrunch- MStocks in focus: Reata Pharmaceuticals stock soars after FDA-drug approval; Novavax falls after vaccine maker issues ‘substantial doubts’ over future operations2 min readmarketwatch.com
- MCrinetics Pharmaceuticals stock surges 24% in trading debutmarketwatch.com
- Reata Pharmaceuticals sets terms for initial public offeringbizjournals.com
Plano’s Reata Pharmaceuticals halts chronic kidney disease drug developmentDallas News- WVinFast stock surges in Wall Street debut on Nasdaqwraltechwire.com
- Plano’s Reata Pharmaceuticals strikes a $7.3 billion deal with biotech giant BiogenDallas News
Coinbase stock surges in debut, valuing crypto exchange at $100 billionNew York Post
Rexahn Pharmaceuticals moving stock listing to Nasdaqthedailyrecord.com- MBiogen agrees to acquire Reata Pharmaceuticals for $7.3 billion to boost its rare-disease offering2 min readmarketwatch.com
Box’s Stock Surges in Debutwsj.com
Instacart surges in trading debutocregister.com- MSucampo Pharmaceuticals' stock surges after Mallinckrodt buyout dealmarketwatch.com
- CSquare's stock surges in Wall Street debutcontracostatimes.com
Roku’s Stock Surges Following Debut Earnings Reportblogs.wsj.com- Shopify surges on double stock market debutbizjournals.com
Etsy stock surges in trading debutThe Toledo Blade- MGrindr Stock Surges 400% in Public Debutmetroweekly.com
Saudi Aramco Surges in Its Trading DebutThe New York Times